We generate selective compounds leveraging
our proprietary G-SMART™ platform
Our Science
* Click on each image to view the original
GENO-K™ is an innovative research platform developed by Genosco that aims to significantly enhance the success rate of kinase inhibitor development. The platform is built upon a proprietary protein database (GENO-K PDB) and a kinase targeting library (GENO-K LDB).
This platform provides a unique approach that selectively targets disease-causing kinases by identifying rare sequences found only in these kinases among 538 human kinases.
Leveraging this technology, we are discovering and developing novel drug candidates for a variety of diseases, including lung cancer, autoimmune diseases, and idiopathic pulmonary fibrosis.
